Sanofi Pasteur, founded in 1990, is a prominent player in the global vaccine industry, emphasizing the prevention of vaccine-preventable diseases. The company's commitment to addressing life-threatening infectious diseases positions it as a crucial player in the Biotechnology and Pharmaceutical sectors.
Operating without a specified headquarters, Sanofi Pasteur serves a wide demographic from children to adults. Its revenue primarily stems from the production and sale of vaccines targeting illnesses such as influenza and meningitis. The company's slogan, "Sanofi Pasteur, vaccine research and innovation, vaccine development," encapsulates its focus on cutting-edge vaccine solutions.
Their last recorded investment was a $43.20M grant on 01 September 2016, backed by notable entities like the US Biomedical Advanced Research and Development Authority and the HHS Administration for Strategic Preparedness and Response. This investment underscores strong governmental trust and strategic positioning in public health preparedness.
